Loading...
Digital health, diagnostics, and medical devices—signals that matter for adoption, reimbursement, and outcomes.
Explore the evolving landscape of noninvasive liver diagnostic devices, understanding the technologies behind them and the organizations advancing this field.
Explore the evolving landscape of noninvasive liver diagnostic devices, understanding the technologies behind them and the organizations advancing this field.
READ MORE
Fullscript’s collaboration with ŌURA marks a significant advance in leveraging wearable biometric data within clinical practice to enhance personalized healthcare delivery.
Machine perfusion technology is revolutionizing organ transplantation by extending organ viability and improving matching between donors and recipients, offering new hope for patients facing scarcity.
Oasys Health has raised $4.6 million, including a significant seed round, to enhance its AI-driven platform tailored for behavioral health management.
Apella secured $80 million in Series B funding to expand its AI-driven platform designed to improve operating room efficiency, increase surgical volume, and reduce clinician burnout without additional infrastructure.
The FDA has announced significant deregulation of digital health products, especially AI-enabled devices and wearables, to foster wider use.
Telehealth companies are quickly offering the obesity drug Wegovy through virtual platforms, tapping into demand for convenient weight management solutions.
Telehealth providers are quickly incorporating the newly approved oral version of Wegovy to meet rising demand for obesity treatments outside traditional clinical settings.
As Novo Nordisk introduces the oral version of its weight-loss drug Wegovy in the U.S., telehealth providers swiftly adopt the pill to meet growing patient demand.
